BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramón Y Cajal S, Sesé M, Capdevila C, Aasen T, De Mattos-Arruda L, Diaz-Cano SJ, Hernández-Losa J, Castellví J. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med (Berl) 2020;98:161-77. [PMID: 31970428 DOI: 10.1007/s00109-020-01874-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 27.5] [Reference Citation Analysis]
Number Citing Articles
1 Franzese C, Cozzi L, Badalamenti M, Baldaccini D, D’agostino G, Fogliata A, Navarria P, Franceschini D, Comito T, Clerici E, Reggiori G, Tomatis S, Scorsetti M. Radiomics-based prognosis classification for high-risk prostate cancer treated with radiotherapy. Strahlenther Onkol. [DOI: 10.1007/s00066-021-01886-y] [Reference Citation Analysis]
2 Zhong QZ, Long LH, Liu A, Li CM, Xiu X, Hou XY, Wu QH, Gao H, Xu YG, Zhao T, Wang D, Lin HL, Sha XY, Wang WH, Chen M, Li GF. Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy. Front Oncol 2020;10:731. [PMID: 32477949 DOI: 10.3389/fonc.2020.00731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
3 Vendramin R, Litchfield K, Swanton C. Cancer evolution: Darwin and beyond. EMBO J 2021;40:e108389. [PMID: 34459009 DOI: 10.15252/embj.2021108389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Murugesan M, Premkumar K. Integrative miRNA-mRNA functional analysis identifies miR-182 as a potential prognostic biomarker in breast cancer. Mol Omics 2021;17:533-43. [PMID: 33884382 DOI: 10.1039/d0mo00160k] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Aramini B, Masciale V, Arienti C, Dominici M, Stella F, Martinelli G, Fabbri F. Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer Associated Fibroblasts (CAFs): A New World of Targets and Treatments. Cancers 2022;14:2408. [DOI: 10.3390/cancers14102408] [Reference Citation Analysis]
6 Laurinavicius A, Rasmusson A, Plancoulaine B, Shribak M, Levenson R. Machine-Learning-Based Evaluation of Intratumoral Heterogeneity and Tumor-Stroma Interface for Clinical Guidance. Am J Pathol 2021:S0002-9440(21)00165-6. [PMID: 33895120 DOI: 10.1016/j.ajpath.2021.04.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gottlieb B, Trifiro M, Batist G. Why Tumor Genetic Heterogeneity May Require Rethinking Cancer Genesis and Treatment. Trends Cancer 2021;7:400-9. [PMID: 33243702 DOI: 10.1016/j.trecan.2020.10.013] [Reference Citation Analysis]
8 Cortés-Selva D, Dasgupta B, Singh S, Grewal IS. Innate and Innate-Like Cells: The Future of Chimeric Antigen Receptor (CAR) Cell Therapy. Trends Pharmacol Sci 2021;42:45-59. [PMID: 33250273 DOI: 10.1016/j.tips.2020.11.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
9 Gaustad JV, Rofstad EK. Assessment of Intratumor Heterogeneity in Parametric Dynamic Contrast-Enhanced MR Images: A Comparative Study of Novel and Established Methods. Front Oncol 2021;11:722773. [PMID: 34621674 DOI: 10.3389/fonc.2021.722773] [Reference Citation Analysis]
10 Tsujikawa T, Mitsuda J, Ogi H, Miyagawa-Hayashino A, Konishi E, Itoh K, Hirano S. Prognostic significance of spatial immune profiles in human solid cancers. Cancer Sci 2020;111:3426-34. [PMID: 32726495 DOI: 10.1111/cas.14591] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Menck K, Sivaloganathan S, Bleckmann A, Binder C. Microvesicles in Cancer: Small Size, Large Potential. Int J Mol Sci 2020;21:E5373. [PMID: 32731639 DOI: 10.3390/ijms21155373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
12 Guo H, Xu K, Duan G, Wen L, He Y. Progress and future prospective of FDG-PET/CT imaging combined with optimized procedures in lung cancer: toward precision medicine. Ann Nucl Med 2021. [PMID: 34727331 DOI: 10.1007/s12149-021-01683-8] [Reference Citation Analysis]
13 Jie W, Bai J, Yan J, Chi Y, Li BB. Multi-Site Tumour Sampling Improves the Detection of Intra-Tumour Heterogeneity in Oral and Oropharyngeal Squamous Cell Carcinoma. Front Med (Lausanne) 2021;8:670305. [PMID: 34041255 DOI: 10.3389/fmed.2021.670305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Javadirad SM, Mokhtari M, Esfandiarpour G, Kolahdouzan M. The pseudogene problem and RT-qPCR data normalization; SYMPK: a suitable reference gene for papillary thyroid carcinoma. Sci Rep 2020;10:18408. [PMID: 33110161 DOI: 10.1038/s41598-020-75495-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Grzywa TM, Koppolu AA, Paskal W, Klicka K, Rydzanicz M, Wejman J, Płoski R, Włodarski PK. Higher Mutation Burden in High Proliferation Compartments of Heterogeneous Melanoma Tumors. Int J Mol Sci 2021;22:3886. [PMID: 33918692 DOI: 10.3390/ijms22083886] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Karahan Şen NP, Aksu A, Kaya GÇ. Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer. Ann Nucl Med 2020;34:960-7. [PMID: 32951129 DOI: 10.1007/s12149-020-01527-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Maria de França G, Andrade ACM, Felix FA, da Silva WR, Almeida DRMF, Leite RB, Galvão HC, Miguel MCDC. Survival-related epithelial-mesenchymal transition proteins in oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis. Arch Oral Biol 2021;131:105267. [PMID: 34592489 DOI: 10.1016/j.archoralbio.2021.105267] [Reference Citation Analysis]
18 Krajnc D, Papp L, Nakuz TS, Magometschnigg HF, Grahovac M, Spielvogel CP, Ecsedi B, Bago-Horvath Z, Haug A, Karanikas G, Beyer T, Hacker M, Helbich TH, Pinker K. Breast Tumor Characterization Using [18F]FDG-PET/CT Imaging Combined with Data Preprocessing and Radiomics. Cancers (Basel) 2021;13:1249. [PMID: 33809057 DOI: 10.3390/cancers13061249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Katz L, Tata A, Woolman M, Zarrine-Afsar A. Lipid Profiling in Cancer Diagnosis with Hand-Held Ambient Mass Spectrometry Probes: Addressing the Late-Stage Performance Concerns. Metabolites 2021;11:660. [PMID: 34677375 DOI: 10.3390/metabo11100660] [Reference Citation Analysis]
20 Skorupa A, Poński M, Ciszek M, Cichoń B, Klimek M, Witek A, Pakuło S, Boguszewicz Ł, Sokół M. Grading of endometrial cancer using 1H HR-MAS NMR-based metabolomics. Sci Rep 2021;11:18160. [PMID: 34518615 DOI: 10.1038/s41598-021-97505-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Attili I, Del Re M, Guerini-Rocco E, Crucitta S, Pisapia P, Pepe F, Barberis M, Troncone G, Danesi R, de Marinis F, Malapelle U, Passaro A. The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies. Expert Rev Mol Diagn 2021;21:757-66. [PMID: 34278933 DOI: 10.1080/14737159.2021.1943365] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Litvin AA, Burkin DA, Kropinov AA, Paramzin FN. Radiomics and Digital Image Texture Analysis in Oncology (Review). Sovrem Tekhnologii Med 2021;13:97-104. [PMID: 34513082 DOI: 10.17691/stm2021.13.2.11] [Reference Citation Analysis]
23 Mahmoud MM, Sanad EF, Elshimy RAA, Hamdy NM. Competitive Endogenous Role of the LINC00511/miR-185-3p Axis and miR-301a-3p From Liquid Biopsy as Molecular Markers for Breast Cancer Diagnosis. Front Oncol 2021;11:749753. [PMID: 34745973 DOI: 10.3389/fonc.2021.749753] [Reference Citation Analysis]
24 Lai CS, Ho CT, Pan MH. The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin. Biomolecules 2020;10:E831. [PMID: 32486019 DOI: 10.3390/biom10060831] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
25 Dias EP, Oliveira NSC, Serra-Campos AO, da Silva AKF, da Silva LE, Cunha KS. A novel evaluation method for Ki-67 immunostaining in paraffin-embedded tissues. Virchows Arch 2021;479:121-31. [PMID: 33464376 DOI: 10.1007/s00428-020-03010-4] [Reference Citation Analysis]
26 Salta S, Macedo-Silva C, Miranda-Gonçalves V, Lopes N, Gigliano D, Guimarães R, Farinha M, Sousa O, Henrique R, Jerónimo C. A DNA methylation-based test for esophageal cancer detection. Biomark Res 2020;8:68. [PMID: 33292587 DOI: 10.1186/s40364-020-00248-7] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Wadowska K, Bil-Lula I, Trembecki Ł, Śliwińska-Mossoń M. Genetic Markers in Lung Cancer Diagnosis: A Review. Int J Mol Sci 2020;21:E4569. [PMID: 32604993 DOI: 10.3390/ijms21134569] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
28 Dawson MR, Xuan B, Hsu J, Ghosh D. Force balancing ACT-IN the tumor microenvironment: Cytoskeletal modifications in cancer and stromal cells to promote malignancy. Int Rev Cell Mol Biol 2021;360:1-31. [PMID: 33962748 DOI: 10.1016/bs.ircmb.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Pfohl U, Pflaume A, Regenbrecht M, Finkler S, Graf Adelmann Q, Reinhard C, Regenbrecht CRA, Wedeken L. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed. Cells 2021;10:928. [PMID: 33920536 DOI: 10.3390/cells10040928] [Reference Citation Analysis]
30 Mashayekhi V, Xenaki KT, van Bergen En Henegouwen PMP, Oliveira S. Dual Targeting of Endothelial and Cancer Cells Potentiates In Vitro Nanobody-Targeted Photodynamic Therapy. Cancers (Basel) 2020;12:E2732. [PMID: 32977602 DOI: 10.3390/cancers12102732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Corrigan AE, Taylor R, Rallis KS. Next-generation sequencing of cancer genomes: lessons learned. Future Oncol 2021;17:4041-4. [PMID: 34431364 DOI: 10.2217/fon-2021-0764] [Reference Citation Analysis]
32 Jain AP, Radhakrishnan A, Pinto S, Patel K, Kumar M, Nanjappa V, Raja R, Keshava Prasad TS, Mathur PP, Sidransky D, Chatterjee A, Gowda H. How to Achieve Therapeutic Response in Erlotinib-Resistant Head and Neck Squamous Cell Carcinoma? New Insights from Stable Isotope Labeling with Amino Acids in Cell Culture-Based Quantitative Tyrosine Phosphoproteomics. OMICS 2021;25:605-16. [PMID: 34432535 DOI: 10.1089/omi.2021.0057] [Reference Citation Analysis]
33 Lau D, McLean MA, Priest AN, Gill AB, Scott F, Patterson I, Carmo B, Riemer F, Kaggie JD, Frary A, Milne D, Booth C, Lewis A, Sulikowski M, Brown L, Lapointe JM, Aloj L, Graves MJ, Brindle KM, Corrie PG, Gallagher FA. Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanoma. J Immunother Cancer 2021;9:e003125. [PMID: 34561275 DOI: 10.1136/jitc-2021-003125] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Tuasha N, Petros B. Heterogeneity of Tumors in Breast Cancer: Implications and Prospects for Prognosis and Therapeutics. Scientifica (Cairo) 2020;2020:4736091. [PMID: 33133722 DOI: 10.1155/2020/4736091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Huang X, Huang K, Johnson T, Radovich M, Zhang J, Ma J, Wang Y. ParsVNN: parsimony visible neural networks for uncovering cancer-specific and drug-sensitive genes and pathways. NAR Genom Bioinform 2021;3:lqab097. [PMID: 34729476 DOI: 10.1093/nargab/lqab097] [Reference Citation Analysis]
36 Betancourt LH, Gil J, Sanchez A, Doma V, Kuras M, Murillo JR, Velasquez E, Çakır U, Kim Y, Sugihara Y, Parada IP, Szeitz B, Appelqvist R, Wieslander E, Welinder C, de Almeida NP, Woldmar N, Marko-Varga M, Eriksson J, Pawłowski K, Baldetorp B, Ingvar C, Olsson H, Lundgren L, Lindberg H, Oskolas H, Lee B, Berge E, Sjögren M, Eriksson C, Kim D, Kwon HJ, Knudsen B, Rezeli M, Malm J, Hong R, Horvath P, Szász AM, Tímár J, Kárpáti S, Horvatovich P, Miliotis T, Nishimura T, Kato H, Steinfelder E, Oppermann M, Miller K, Florindi F, Zhou Q, Domont GB, Pizzatti L, Nogueira FCS, Szadai L, Németh IB, Ekedahl H, Fenyö D, Marko-Varga G. The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome. Clin Transl Med 2021;11:e451. [PMID: 34323402 DOI: 10.1002/ctm2.451] [Reference Citation Analysis]
37 Andrieux G, Chakraborty S. Editorial: Integration of Multi-Omics Techniques in Cancer. Front Genet 2021;12:733965. [PMID: 34434225 DOI: 10.3389/fgene.2021.733965] [Reference Citation Analysis]
38 Suri R, Zimmerman JW, Burkhart RA. Modeling human pancreatic ductal adenocarcinoma for translational research: current options, challenges, and prospective directions. Ann Pancreat Cancer 2020;3:17. [PMID: 33889840 DOI: 10.21037/apc-20-29] [Reference Citation Analysis]
39 Damasco JA, Ravi S, Perez JD, Hagaman DE, Melancon MP. Understanding Nanoparticle Toxicity to Direct a Safe-by-Design Approach in Cancer Nanomedicine. Nanomaterials (Basel) 2020;10:E2186. [PMID: 33147800 DOI: 10.3390/nano10112186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
40 Yu T. COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer. Eur J Radiol 2020;132:109338. [PMID: 33068840 DOI: 10.1016/j.ejrad.2020.109338] [Reference Citation Analysis]
41 Anduran E, Aspatwar A, Parvathaneni NK, Suylen D, Bua S, Nocentini A, Parkkila S, Supuran CT, Dubois L, Lambin P, Winum JY. Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation. Molecules 2020;25:E2347. [PMID: 32443462 DOI: 10.3390/molecules25102347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Gurova K. Can aggressive cancers be identified by the "aggressiveness" of their chromatin? Bioessays 2022;:e2100212. [PMID: 35452144 DOI: 10.1002/bies.202100212] [Reference Citation Analysis]
43 Panchal A, Seto P, Wall R, Hillier BJ, Zhu Y, Krakow J, Datt A, Pongo E, Bagheri A, Chen TT, Degenhardt JD, Culp PA, Dettling DE, Vinogradova MV, May C, DuBridge RB. COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors. MAbs 2020;12:1792130. [PMID: 32684124 DOI: 10.1080/19420862.2020.1792130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
44 Cioce M, Sacconi A, Pass HI, Canino C, Strano S, Blandino G, Fazio VM. Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature. Int J Mol Sci 2021;22:12071. [PMID: 34769499 DOI: 10.3390/ijms222112071] [Reference Citation Analysis]
45 Truong LH, Pauklin S. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches. Cancers (Basel) 2021;13:5028. [PMID: 34638513 DOI: 10.3390/cancers13195028] [Reference Citation Analysis]
46 Lavallee E, Sfakianos JP, Mulholland DJ. Tumor Heterogeneity and Consequences for Bladder Cancer Treatment. Cancers (Basel) 2021;13:5297. [PMID: 34771460 DOI: 10.3390/cancers13215297] [Reference Citation Analysis]
47 Barkley D, Rao A, Pour M, França GS, Yanai I. Cancer cell states and emergent properties of the dynamic tumor system. Genome Res 2021;31:1719-27. [PMID: 34599005 DOI: 10.1101/gr.275308.121] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Ieni A, Vita R, Pizzimenti C, Benvenga S, Tuccari G. Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine. J Pers Med 2021;11:333. [PMID: 33922518 DOI: 10.3390/jpm11050333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Ma S, Zhang Y. Profiling chromatin regulatory landscape: insights into the development of ChIP-seq and ATAC-seq. Mol Biomed 2020;1. [DOI: 10.1186/s43556-020-00009-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
50 Baliu-Piqué M, Pandiella A, Ocana A. Breast Cancer Heterogeneity and Response to Novel Therapeutics. Cancers (Basel) 2020;12:E3271. [PMID: 33167363 DOI: 10.3390/cancers12113271] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
51 Wu W, Klockow JL, Zhang M, Lafortune F, Chang E, Jin L, Wu Y, Daldrup-Link HE. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol Res 2021;171:105780. [PMID: 34302977 DOI: 10.1016/j.phrs.2021.105780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Zhao T, Chiang ZD, Morriss JW, LaFave LM, Murray EM, Del Priore I, Meli K, Lareau CA, Nadaf NM, Li J, Earl AS, Macosko EZ, Jacks T, Buenrostro JD, Chen F. Spatial genomics enables multi-modal study of clonal heterogeneity in tissues. Nature 2021. [PMID: 34912115 DOI: 10.1038/s41586-021-04217-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Parker TM, Gupta K, Palma AM, Yekelchyk M, Fisher PB, Grossman SR, Won KJ, Madan E, Moreno E, Gogna R. Cell competition in intratumoral and tumor microenvironment interactions. EMBO J 2021;40:e107271. [PMID: 34368984 DOI: 10.15252/embj.2020107271] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
54 Chen Z, Huang Y, Hu Z, Zhao M, Li M, Bi G, Zheng Y, Liang J, Lu T, Jiang W, Xu S, Zhan C, Xi J, Wang Q, Tan L. Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma. Clin Transl Med 2021;11:e350. [PMID: 33783985 DOI: 10.1002/ctm2.350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Berg HF, Hjelmeland ME, Lien H, Espedal H, Fonnes T, Srivastava A, Stokowy T, Strand E, Bozickovic O, Stefansson IM, Bjørge L, Trovik J, Haldorsen IS, Hoivik EA, Krakstad C. Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. Commun Med 2021;1. [DOI: 10.1038/s43856-021-00019-x] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Spivak AY, Nedopekina DA, Gubaidullin RR, Dubinin MV, Belosludtsev KN. Conjugation of Natural Triterpenic Acids with Delocalized Lipophilic Cations: Selective Targeting Cancer Cell Mitochondria. J Pers Med 2021;11:470. [PMID: 34070567 DOI: 10.3390/jpm11060470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
57 Schurink NW, van Kranen SR, Berbee M, van Elmpt W, Bakers FCH, Roberti S, van Griethuysen JJM, Min LA, Lahaye MJ, Maas M, Beets GL, Beets-Tan RGH, Lambregts DMJ. Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer. Eur Radiol 2021;31:7031-8. [PMID: 33569624 DOI: 10.1007/s00330-021-07724-0] [Reference Citation Analysis]
58 Lin SR, Yeh HL, Liu YN. Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation. Cancers (Basel) 2021;13:3452. [PMID: 34298665 DOI: 10.3390/cancers13143452] [Reference Citation Analysis]
59 Kabzinski J, Maczynska M, Majsterek I. MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer. Biomolecules 2021;11:844. [PMID: 34198889 DOI: 10.3390/biom11060844] [Reference Citation Analysis]
60 Hou J, He Z, Liu T, Chen D, Wang B, Wen Q, Zheng X. Evolution of Molecular Targeted Cancer Therapy: Mechanisms of Drug Resistance and Novel Opportunities Identified by CRISPR-Cas9 Screening. Front Oncol 2022;12:755053. [DOI: 10.3389/fonc.2022.755053] [Reference Citation Analysis]
61 Zhang Y, Xie A, Quan F, Hou X, Liao J, Zhu S, Pang L, Liang X, Zhu X, Cheng P, Li X, Xiao Y. Identifying bifurcated paths with differential function impact in glioblastomas evolution. Int J Cancer 2020;147:3139-51. [PMID: 32875565 DOI: 10.1002/ijc.33276] [Reference Citation Analysis]
62 da Cruz LLP, de Souza PO, Dal Prá M, Falchetti M, de Abreu AM, Azambuja JH, Bertoni APS, Paz AHR, Araújo AB, Visioli F, Fazolo T, da Silva GG, Worm PV, Wink MR, Zanotto-Filho A, Braganhol E. TLR4 expression and functionality are downregulated in glioblastoma cells and in tumor-associated macrophages: A new mechanism of immune evasion? Biochim Biophys Acta Mol Basis Dis 2021;1867:166155. [PMID: 33932524 DOI: 10.1016/j.bbadis.2021.166155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Elkhader J, Elemento O. Artificial intelligence in oncology: From bench to clinic. Semin Cancer Biol 2021:S1044-579X(21)00114-0. [PMID: 33915289 DOI: 10.1016/j.semcancer.2021.04.013] [Reference Citation Analysis]
64 Ashfaq M, Talreja N, Chauhan D, Afreen S, Sultana A, Srituravanich W. Two-dimensional (2D) hybrid nanomaterials for diagnosis and treatment of cancer. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103268] [Reference Citation Analysis]
65 Moon SW, Son HJ, Mo HY, Yoo NJ, Lee SH. Somatic Mutation of NLRP Genes in Gastric and Colonic Cancers. Pathol Oncol Res 2021;27:607385. [PMID: 34257569 DOI: 10.3389/pore.2021.607385] [Reference Citation Analysis]
66 Rossi T, Gallerani G, Martinelli G, Maltoni R, Fabbri F. Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue. Biomedicines 2021;9:1242. [PMID: 34572427 DOI: 10.3390/biomedicines9091242] [Reference Citation Analysis]
67 Metzenmacher M, Hegedüs B, Forster J, Schramm A, Horn PA, Klein CA, Bielefeld N, Ploenes T, Aigner C, Theegarten D, Schildhaus HU, Siveke JT, Schuler M, Lueong SS. Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer. Transl Oncol 2021;15:101279. [PMID: 34800919 DOI: 10.1016/j.tranon.2021.101279] [Reference Citation Analysis]
68 Sharma M, Verma RK, Kumar S, Kumar V. Computational challenges in detection of cancer using cell-free DNA methylation. Comput Struct Biotechnol J 2022;20:26-39. [PMID: 34976309 DOI: 10.1016/j.csbj.2021.12.001] [Reference Citation Analysis]
69 Jeong YM, Bang C, Park M, Shin S, Yun S, Kim CM, Jeong G, Chung YJ, Yun WS, Lee JH, Jin S. 3D-Printed Collagen Scaffolds Promote Maintenance of Cryopreserved Patients-Derived Melanoma Explants. Cells 2021;10:589. [PMID: 33800001 DOI: 10.3390/cells10030589] [Reference Citation Analysis]
70 Piemonte KM, Anstine LJ, Keri RA. Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer. Endocrinology 2021;162:bqab208. [PMID: 34606589 DOI: 10.1210/endocr/bqab208] [Reference Citation Analysis]